Cardiff Oncology Inc. buy quelbe60
Start price
20.02.22
/
50%
€2.52
Target price
20.02.23
-
Performance (%)
-16.67%
End price
05.03.22
€2.10
Summary
This prediction ended on 05.03.22 with a price of €2.10. The price of Cardiff Oncology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.67%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -5.924% | -5.924% | 60.723% | 43.936% |
| iShares Core DAX® | 0.200% | 4.061% | 32.572% | 79.696% |
| iShares Nasdaq 100 | 1.230% | 5.596% | 10.743% | 62.379% |
| iShares Nikkei 225® | 0.348% | 0.896% | -0.367% | 16.852% |
| iShares S&P 500 | 0.438% | 4.263% | 7.698% | 42.949% |
Comments by quelbe60 for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.